Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Non-cash Items (2023 - 2026)

MBX Biosciences has reported Non-cash Items over the past 4 years, most recently at $2.3 million for Q1 2026.

  • Quarterly results put Non-cash Items at $2.3 million for Q1 2026, down 4.44% from a year ago — trailing twelve months through Mar 2026 was $2.3 million (down 4.44% YoY), and the annual figure for FY2025 was $2.3 million, down 5.48%.
  • Non-cash Items reached $2.3 million in Q1 2026 per MBX's latest filing, down from $97.8 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $97.8 million in Q4 2025 and bottomed at $2.3 million in Q1 2026.
  • Median Non-cash Items over the past 4 years was $17.6 million (2025), compared with a mean of $30.0 million.
  • The largest annual shift saw Non-cash Items soared 655.16% in 2024 before it tumbled 64.68% in 2025.
  • Over 4 years, Non-cash Items stood at $4.5 million in 2023, then skyrocketed by 655.16% to $34.3 million in 2024, then skyrocketed by 184.93% to $97.8 million in 2025, then plummeted by 97.67% to $2.3 million in 2026.
  • Business Quant data shows Non-cash Items for MBX at $2.3 million in Q1 2026, $97.8 million in Q4 2025, and $22.3 million in Q3 2025.